Skip to main content
Clinical Trials/NCT05590533
NCT05590533
Not yet recruiting
Not Applicable

Validity and Reliability of the Turkish Version of F-2-MS Scale

Pamukkale University0 sites180 target enrollmentNovember 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cultural Adaptation
Sponsor
Pamukkale University
Enrollment
180
Primary Endpoint
F-2-MS Scale
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

The aims of this study were to perform cultural adaptation of the F-2-MS and provide information regarding the factor structure, reliability and validity of the instrument in Turkish speaking patients with Multiple Sclerosis.

Registry
clinicaltrials.gov
Start Date
November 2022
End Date
May 2023
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ayşe Ünal

Assoc. Prof.

Pamukkale University

Eligibility Criteria

Inclusion Criteria

  • Individuals aged between 20-65 years, with an EDSS score of 0-5, who have not had an attack in the last 2 months, who have no cognitive problems (a score of 6 or more according to the Hodkinson Mental Test), who do not have additional neurological diseases other than MS, and who volunteer to participate in the study will be included.

Exclusion Criteria

  • Individuals with an EDSS score greater than 5, who are in the attack period, who have vestibulosupressant or drug or alcohol use habits that cause neuropathy, and who have communication problems will be excluded from the study.

Outcomes

Primary Outcomes

F-2-MS Scale

Time Frame: 10 minutes

F-2-MS is a novel scale to assess fatigue and perceived fatigability in patients with MS

Similar Trials